Argus downgraded Wendy’s to Hold from Buy, citing soft U.S. sales and traffic that are weighing on results despite gains overseas.
Lifespan Vision Ventures is pleased to announce that its portfolio company, Remedium Bio, Inc. ("Remedium"), has entered into a multi-target research and development collaboration with Eli Lilly and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback